Objective: Compare performance between an injury prediction model categorising predictors and one that did not and compare a selection of predictors based on univariate significance versus assessing non-linear relationships.

Methods: Validation and replication of a previously developed injury prediction model in a cohort of 1466 service members followed for 1 year after physical performance, medical history and sociodemographic variables were collected. The original model dichotomised 11 predictors. The second model (M2) kept predictors continuous but assumed linearity and the third model (M3) conducted non-linear transformations. The fourth model (M4) chose predictors the proper way (clinical reasoning and supporting evidence). Model performance was assessed with R, calibration in the large, calibration slope and discrimination. Decision curve analyses were performed with risk thresholds from 0.25 to 0.50.

Results: 478 personnel sustained an injury. The original model demonstrated poorer R (original:0.07; M2:0.63; M3:0.64; M4:0.08), calibration in the large (original:-0.11 (95% CI -0.22 to 0.00); M2: -0.02 (95% CI -0.17 to 0.13); M3:0.03 (95% CI -0.13 to 0.19); M4: -0.13 (95% CI -0.25 to -0.01)), calibration slope (original:0.84 (95% CI 0.61 to 1.07); M2:0.97 (95% CI 0.86 to 1.08); M3:0.90 (95% CI 0.75 to 1.05); M4: 081 (95% CI 0.59 to 1.03) and discrimination (original:0.63 (95% CI 0.60 to 0.66); M2:0.90 (95% CI 0.88 to 0.92); M3:0.90 (95% CI 0.88 to 0.92); M4: 0.63 (95% CI 0.60 to 0.66)). At 0.25 injury risk, M2 and M3 demonstrated a 0.43 net benefit improvement. At 0.50 injury risk, M2 and M3 demonstrated a 0.33 net benefit improvement compared with the original model.

Conclusion: Model performance was substantially worse in the models with dichotomised variables. This highlights the need to follow established recommendations when developing prediction models.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577931PMC
http://dx.doi.org/10.1136/bmjsem-2022-001388DOI Listing

Publication Analysis

Top Keywords

injury risk
12
95%
12
model
9
injury prediction
8
prediction model
8
original model
8
model performance
8
calibration large
8
calibration slope
8
m3090 95%
8

Similar Publications

Background: Hypoxia-inducible factor 1 alpha (HIF-1α) and its related vascular endothelial growth factor (VEGF) may play a significant role in atherosclerosis and their targeting is a strategic approach that may affect multiple pathways influencing disease progression. This study aimed to perform a systematic review to reveal current evidence on the role of HIF-1α and VEGF immunophenotypes with other prognostic markers as potential biomarkers of atherosclerosis prognosis and treatment efficacy.

Methods: We performed a systematic review of the current literature to explore the role of HIF-1α and VEGF protein expression along with the relation to the prognosis and therapeutic strategies of atherosclerosis.

View Article and Find Full Text PDF

The burdens of cardiovascular (CV) diseases and cardiotoxic side effects of cancer treatment in oncology patients are increasing in parallel. The European Society of Cardiology (ESC) 2022 Cardio-Oncology guidelines recommend the use of standardized risk stratification tools to determine the risk of cardiotoxicity associated with different anticancer treatment modalities and the severity of their complications. The use of the Heart Failure Association-International Cardio-Oncology Society (HFA-ICOS) is essential for assessing risk prior to starting cancer treatment, and validation of these methods has been performed in patients receiving anthracyclines, human epidermal receptor 2 (HER2)-targeted therapies and breakpoint cluster region-abelson oncogene locus (BCR-ABL) inhibitors.

View Article and Find Full Text PDF

Placenta accreta spectrum (PAS) poses a significant risk for maternal morbidity and mortality. There is a global rise in incidence of PAS in tandem with an increase in rates of cesarian section. Previous cesarian section and presence of placenta previa are two independent risk factors for development of PAS.

View Article and Find Full Text PDF

The Potential of Neonatal Organ Donation in Central Sweden.

Cell Transplant

January 2025

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Pediatric organ transplant recipients have a higher risk for wait list mortality due to the scarcity of size matched organs. Neonatal organ donation could potentially ameliorate the discrepancy but is currently not implemented in Sweden. This study aims to evaluate the potential of neonatal organ donation in central Sweden using a standardized protocol with organ specific criteria.

View Article and Find Full Text PDF

The effects of a concomitant infection of hepatitis B virus (HBV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still debated, with a recognized major risk of HBV reactivation during immune-suppressive treatments. The aim of this study was to determine the prevalence and predictive factors of HBV reactivation in a cohort of hospitalized patients with coronavirus disease 2019 (COVID-19) and a current or past hepatitis B infection. In a monocentric retrospective observational study, we enrolled all consecutive hospital admitted patients with COVID-19 pneumonia and a positive HBV serology (N = 84) in our Infectious Diseases Unit from April 2021 to December 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!